Radiation oncology at Jefferson has a long and impressive record. As early as
1901, clinicians at the hospital used X-ray radiation to treat cancer and other
conditions. In the decade after 1904, Jefferson clinicians administered many hundreds of
radium treatments annually.
Already by 1932, junior Jefferson radiology students were receiving weekly instruction
in radium therapy. By the 1940s, the hospital had a physician serving on its staff who was
a fully accredited radiation therapist. By the 1950s, the hospital had its first clinical
physicist, had built a physics laboratory, and had organized radiation therapy as a
separate division. In the late 50s and early 60s, it installed its first teletherapy
units.
By 1969, Jefferson had the first radiationtherapy simulator in the United States. In
the late 60s, and in the 70s under the leadership and chairmanship of Simon Kramer, MD,
radiation oncology became a separate department at the university, and research efforts
increased, with Jefferson organizing some of the first national, randomized studies in the
field. Dr. Kramer helped organize the Radiation Therapy Oncology Group and bring basic and
clinical research, and physical facilities, of the department into the modern era.
Carl Mansfield, MD, chaired the department from 1983 to 1994, overseeing a host of
important enhancements. This period saw the opening of Jeffersons Bodine Center for
Cancer Treatment, a three-floor, 57,000 square foot, outpatient facility dedicated to
radiation oncology. Dr. Mansfield who managed many pioneering developments in the
department ¾ in such areas as intraoperative radiation therapy
and innovative approaches to brachytherapy ¾ went on to a
leadership position at the National Cancer Institute and Chairman of Radiation Oncology at
the University of Maryland.
Walter J. Curran, Jr., MD, chairman of the department since 1994 and an international
authority on lung cancer and brain tumor treatment, continues the departments strong
tradition of leadership. In just a few years under his guidance, the department has
achieved a far-reaching reputation in clinical trials, innovative patient care, and an
increase in the number of community centers.